Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Mol Imaging Biol. 2011 Feb;13(1):121–127. doi: 10.1007/s11307-010-0304-2

Fig. 4.

Fig. 4

Organ clearance kinetics from imaging quantification in normal dogs administered 99mTcN-MPO (a) or 99mTc-Sestamibi (b). The liver activity of 99mTcN-MPO was markedly decreased within the first 60 min, whereas 99mTc-Sestamibi had a slower reduction in liver activity over time. A mild myocardial washout was observed in the dogs administered 99mTcN-MPO. No significant myocardial washout was seen in the dogs administered 99mTc-Sestamibi.